HC Wainwright & Co. Maintains Buy on NeuroPace, Raises Price Target to $20
Neuropace Inc NPCE
$16.92
▲ +3.93%
(+$0.64)
Open
$16.38
Prev Close
$16.28
Day Range
$16.38 – $17.10
52W Range
$7.56 – $19.60
Market Cap
$576.87M
Beta
1.94
EPS (TTM)
$-0.65
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-04-22 |
| Shares Out. | 34,090,000 |
| Website | neuropace.com/ ↗ |
| Phone | 16502372700 |
Neuropace Inc is a publicly traded company under the ticker symbol NPCE on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
14 analysts (2026-05-01)
📰 Latest News for NPCE
NeuroPace, Inc. (NPCE) Q1 2026 Earnings Call Transcript
Transcript : NeuroPace, Inc., Q1 2026 Earnings Call, May 12, 2026
NeuroPace (NASDAQ:NPCE) Beats Q1 Estimates, Raises Full-Year Revenue Guidance
NeuroPace : Investor Presentation
NeuroPace Reports Q1 2026 Results: Full Earnings Call Transcript
NeuroPace Inc.: Q1 Earnings Snapshot
NeuroPace Raises FY2026 Sales Guidance from $98.000M-$100.000M to $99.000M-$101.000M vs $98.910M Est